Mici Phillips

652 total citations
14 papers, 346 citations indexed

About

Mici Phillips is a scholar working on Physiology, Molecular Biology and Organic Chemistry. According to data from OpenAlex, Mici Phillips has authored 14 papers receiving a total of 346 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Physiology, 8 papers in Molecular Biology and 7 papers in Organic Chemistry. Recurrent topics in Mici Phillips's work include Lysosomal Storage Disorders Research (14 papers), Carbohydrate Chemistry and Synthesis (7 papers) and Glycosylation and Glycoproteins Research (5 papers). Mici Phillips is often cited by papers focused on Lysosomal Storage Disorders Research (14 papers), Carbohydrate Chemistry and Synthesis (7 papers) and Glycosylation and Glycoproteins Research (5 papers). Mici Phillips collaborates with scholars based in Israel, United States and Mexico. Mici Phillips's co-authors include Gregory M. Pastores, Ana Cristina Puga, Elena Lukina, Nora Watman, Marta Dragosky, Hanna Rosenbaum, Elsa Ávila Arreguin, Mathilde Kaper, Marcelo Iastrebner and Daniel I. Rosenthal and has published in prestigious journals such as Blood, Molecular Genetics and Metabolism and Journal of Inherited Metabolic Disease.

In The Last Decade

Mici Phillips

14 papers receiving 333 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mici Phillips Israel	8	321	144	139	128	116	14	346
Elsa Ávila Arreguin Mexico	6	397 1.2×	163 1.1×	189 1.4×	184 1.4×	137 1.2×	15	418
Linda Berná Czechia	10	361 1.1×	107 0.7×	152 1.1×	96 0.8×	135 1.2×	11	420
Laurie Bailey United States	9	304 0.9×	136 0.9×	110 0.8×	91 0.7×	79 0.7×	20	346
Kristiane Michelin‐Tirelli Brazil	11	288 0.9×	88 0.6×	123 0.9×	83 0.6×	98 0.8×	23	347
Marcelo Iastrebner Argentina	5	236 0.7×	96 0.7×	116 0.8×	107 0.8×	97 0.8×	21	290
Sabrina Eichler Germany	10	251 0.8×	87 0.6×	94 0.7×	77 0.6×	111 1.0×	15	324
Hui-Ying Yeh Taiwan	4	295 0.9×	83 0.6×	133 1.0×	93 0.7×	56 0.5×	6	326
Carole Elbin United States	6	321 1.0×	53 0.4×	112 0.8×	59 0.5×	53 0.5×	8	373
Tanya Collin-Histed United Kingdom	7	231 0.7×	153 1.1×	80 0.6×	87 0.7×	63 0.5×	13	252
Grabowski Ga United States	7	287 0.9×	119 0.8×	113 0.8×	106 0.8×	131 1.1×	9	312

Countries citing papers authored by Mici Phillips

Since Specialization

Citations

This map shows the geographic impact of Mici Phillips's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mici Phillips with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mici Phillips more than expected).

Fields of papers citing papers by Mici Phillips

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mici Phillips. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mici Phillips. The network helps show where Mici Phillips may publish in the future.

Co-authorship network of co-authors of Mici Phillips

This figure shows the co-authorship network connecting the top 25 collaborators of Mici Phillips. A scholar is included among the top collaborators of Mici Phillips based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mici Phillips. Mici Phillips is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Alcalay, Roy N., Bettina Steiner‐Birmanns, Gheona Altarescu, et al.. (2012). Phenotype in patients with Gaucher disease and Parkinson disease. Blood Cells Molecules and Diseases. 50(3). 218–221. 31 indexed citations

Peterschmitt, Michel, Elena Lukina, Nora Watman, et al.. (2012). Eliglustat, an Investigational Oral Therapy for Gaucher Disease Type 1 (GD1): Updated Phase 2 Results. Molecular Genetics and Metabolism. 105(2). S52–S52. 1 indexed citations

Elstein, Deborah, Gheona Altarescu, Mici Phillips, et al.. (2011). Booster-effect with velaglucerase alfa in patients with Gaucher disease switched from long-term imiglucerase therapy: Early Access Program results from Jerusalem. Blood Cells Molecules and Diseases. 48(1). 45–50. 19 indexed citations

Peterschmitt, Michel, Elena Lukina, Nora Watman, et al.. (2011). Eliglustat, An Investigational Oral Therapy for Gaucher Disease Type 1: Phase 2 Results After 3 Years. Blood. 118(21). 1104–1104. 2 indexed citations

Peterschmitt, Michel, Ravi S. Kamath, Elena Lukina, et al.. (2011). Improvements in Skeletal Manifestations in Gaucher Disease Type 1 Patients After 3 Years of Treatment with Oral Eliglustat During a Phase 2 Trial,. Blood. 118(21). 3216–3216. 1 indexed citations

Puga, Ana Cristina, Elena Lukina, Nora Watman, et al.. (2011). Eliglustat, an investigational oral therapy for gaucher disease type 1 (GD1): Phase 2 results and assessment of patient responses and achievement of established therapeutic goals after 2 years of treatment. Molecular Genetics and Metabolism. 102(2). S37–S37. 2 indexed citations

Abrahamov, Ayala, et al.. (2010). Sixteen years of prenatal consultations for the N370S/N370S Gaucher disease genotype: What have we learned?. Prenatal Diagnosis. 30(10). 924–927. 9 indexed citations

Lukina, Elena, Nora Watman, Elsa Ávila Arreguin, et al.. (2010). A phase 2 study of eliglustat tartrate (Genz-112638), an oral substrate reduction therapy for Gaucher disease type 1. Blood. 116(6). 893–899. 120 indexed citations

Elstein, Deborah, Gheona Altarescu, Aya Abrahamov, et al.. (2010). Disease severity in sibling pairs with type 1 Gaucher disease. Journal of Inherited Metabolic Disease. 33(1). 79–83. 17 indexed citations

10.

Lukina, Elena, Nora Watman, Elsa Ávila Arreguin, et al.. (2010). Improvement in hematological, visceral, and skeletal manifestations of Gaucher disease type 1 with oral eliglustat tartrate (Genz-112638) treatment: 2-year results of a phase 2 study. Blood. 116(20). 4095–4098. 122 indexed citations

11.

Lukina, Elena, Nora Watman, Marta Dragosky, et al.. (2010). Eliglustat Tartrate, a Novel Investigational Oral Substrate Reduction Therapy for Gaucher Disease Type 1: Updated Phase 2 Results.. Blood. 116(21). 3791–3791. 1 indexed citations

12.

Lebel, Ehud, Mici Phillips, Deborah Elstein, Ari Zimran, & Menachem Itzchaki. (2009). Poor results of drilling in early stages of juxta-articular osteonecrosis in 12 joints affected by Gaucher disease. Acta Orthopaedica. 80(2). 201–204. 9 indexed citations

13.

Lukina, Elena, Nora Watman, Elsa Ávila Arreguin, et al.. (2009). Genz-112638 for Gaucher Disease Type 1: Phase 2 Clinical Trial Results After 18 Months of Treatment.. Blood. 114(22). 1349–1349. 3 indexed citations

14.

Phillips, Mici, Ehud Lebel, A. Joseph Foldes, et al.. (2008). Molecular aspects of osteopathy in type 1 Gaucher disease: correlation between genetics and bone density. Rheumatology International. 28(9). 873–877. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact